Antibody Drug Conjugates (ADCs) in NSCLC
Podcast | English | 39 Min
Image For Activity Cover
Credit
No Credit Offered
What are Antibody Drug Conjugates, and do they have a promising future in lung cancer treatment? To discuss this topic, Lung Cancer Considered host Dr. Stephen Liu is joined by Dr. Rebecca Heist, associate director of clinical research at Massachusetts General Hospital Cancer Center in Boston, and Dr. Ben Levy, clinical director of medical oncology at the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center in Baltimore.

Podcast Hosts:

  • Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA 

Podcast Guests: 

  • Rebecca Heist, MD, Associate Professor of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA
  • Ben Levy, MD, Associate Professor, Johns Hopkins School of Medicine, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, USA
Powered By